RESUMO
The biomimetic design of engineering structures is based on biological structures with excellent mechanical properties, which are the result of billions of years of evolution. However, current biomimetic structures, such as ordered lattice materials, are still inferior to many biomaterials in terms of structural complexity and mechanical properties. For example, the structure ofEuplectella aspergillum, a type of deep-sea glass sponge, is an eye-catching source of inspiration for biomimetic design, many researches have introduced similar architecture in cellular solids. However, guided by scientific theory, how to surpass the mechanical properties ofE. aspergillumremains an unsolved problem. We proposed the lattice structure which firstly surpass theE. aspergillummechanically. The lattice structure of the skeleton ofE. aspergillumconsists of vertically, horizontally, and diagonally oriented struts, which provide superior strength and flexural resistance compared with the conventional square lattice structure. Herein, the structure ofE. aspergillumwas investigated in detail, and by using the theory of elasticity, a lattice structure inspired by the biomimetic structure was proposed. The mechanical properties of the sponge-inspired lattice structure surpassed the sponge structure under a variety of loading conditions, and the excellent performance of this configuration was verified experimentally. The proposed lattice structure can greatly improve the mechanical properties of engineering structures, and it improves strength without much redundancy of material. This study achieved the first surpassing of the mechanical properties of an existing sponge-mimicking design. This design can be applied to lattice structures, truss systems, and metamaterial cells.
Assuntos
Materiais Biocompatíveis , Vidro , Materiais Biocompatíveis/química , Resistência à Flexão , Elasticidade , BiomiméticaRESUMO
Post-stroke cognitive impairment (PSCI) severely affects the quality of a survivor's life, but its neurophysiological basis remains unknown. Neuroinflammation has been considered as an important contributor to PSCI, which could be induced or exacerbated by system inflammation. NACHT-LRR- and pyrin-domain-containing protein 3 (NLRP3) inflammasome is the most widely studied in the initiation of inflammation. Here, using a mouse model of photothrombotic stroke, we demonstrated that NLRP3 activation plays a critical role in PSCI. Intraperitoneal injection of the lipopolysaccharide-activated NLRP3 inflammasome, exacerbated the microglial activation and decreased the number of neurons, impaired the hippocampal neurogenesis, eventually aggravated PSCI. Intraperitoneal injection of MCC950 inhibited the NLRP3 activation, decreased the number of microglia, increased the number of neurons and promoted the hippocampal neurogenesis, eventually improved PSCI. Our results identified NLRP3 inflammasome as an important modifier of neuropathology in PSCI, which could be a could be a potential therapeutic target for PSCI treatment.